EPS for ICC International Cannabis (ICC) Expected At $-0.01; Semileds (LEDS) Shorts Down By 1.58%

November 15, 2017 - By Adrian Erickson

Semileds Corporation (NASDAQ:LEDS) had a decrease of 1.58% in short interest. LEDS’s SI was 111,800 shares in November as released by FINRA. Its down 1.58% from 113,600 shares previously. With 17,700 avg volume, 6 days are for Semileds Corporation (NASDAQ:LEDS)’s short sellers to cover LEDS’s short positions. The SI to Semileds Corporation’s float is 7.13%. The stock increased 10.95% or $0.28 during the last trading session, reaching $2.8. About shares traded. SemiLEDs Corporation (NASDAQ:LEDS) has risen 84.21% since November 15, 2016 and is uptrending. It has outperformed by 67.51% the S&P500.

Analysts expect ICC International Cannabis Corp (CVE:ICC) to report $-0.01 EPS on December, 5.After having $-0.01 EPS previously, ICC International Cannabis Corp’s analysts see 0.00% EPS growth. It closed at $1.03 lastly. It is up 0.00% since November 15, 2016 and is . It has underperformed by 16.70% the S&P500.

SemiLEDs Corporation develops, manufactures and sells light emitting diode chips and LED components. The company has market cap of $9.91 million. The Company’s products are used primarily for general lighting applications, including street lights and commercial, industrial and residential lighting. It currently has negative earnings. The Company’s LED chips may also be used in specialty industrial applications, such as ultraviolet (UV), curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting.

ICC International Cannabis Corp, formerly Shogun Capital Corp, is a Canada company, which is a licensed cannabis producer, investigator and vendor. The company has market cap of $115.94 million. The principal activities of the Company are the production and sale of cannabis from its facilities in Uruguay. It currently has negative earnings. The Firm is focused on the licensed production, development and sale of recreational cannabis, cannabinoid extracts and by-products for medicinal uses and industrial hemp.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com